Moderna expects to have Omicron booster ready by Fall 2022
Moderna expects to have an Omicron booster that combines its original COVID-19 vaccine with one targeting the variant ready by Fall 2022.
Moderna applies for approval of COVID-19 vaccine for children
Moderna has asked the FDA to authorize its COVID-19 vaccine for children ages 6 months through 5 years.
America’s “Test to Treat” has failed. Here’s how to fix it.
So far, Test to Treat has largely failed to get antivirals for COVID-19 to patients that need them — but the initiative can still be fixed.
WeChat users try to keep Shanghai lockdown protest video ahead of censors
WeChat users have turned to all manner of tricks in a cat-and-mouse game with CCP censors to keep a video about the Shanghai lockdown online.
Strange treatment may restore sense of smell after COVID
Philadelphia doctors are treating COVID patient’s loss of smell with plasma-soaked sponges. But whether it is working or not still needs to be sniffed out.
New UV light safely kills 98% of airborne pathogens indoors
Far-UVC light — a type of ultraviolet light that isn’t harmful to human health — killed 98% of airborne microbes indoors in a new study.
Vaccine used to treat COVID-19 for first time
A man whose persistent coronavirus infection kept him isolated for 7 months finally tested negative after receiving a COVID-19 vaccine.
One shot of this COVID-19 drug reduces risk of death by 60%
In-development COVID-19 drug Peginterferon Lambda reduced risk of hospitalization or lengthy emergency room visits by 50% in a phase 3 trial.
China’s COVID-19 cases surge, with low elderly vaccination rates
China’s “zero-COVID” policies may be contributing to a surge of cases that has forced 50 million people into lockdown.